Project Details
Description
A Prospective, Non-interventional (NIS), Long-Term, Post-Authorisation Safety Study (PASS) of Patients Treated with Lonapegsomatropin
| Status | Active |
|---|---|
| Effective start/end date | 7/31/23 → 7/31/33 |
Funding
- ASCENDIS PHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.